Evidence map›Paper›PMID 23007727›Full record

ArticleArchives of pediatrics & adolescent medicine2012

Obesity, metabolic syndrome, and insulin resistance in urban high school students of minority race/ethnicity.

Michael Turchiano, Victoria Sweat, Arthur Fierman, Antonio Convit

Open access · greenAbstract readComparative Study
In one paragraph

Article in Archives of pediatrics & adolescent medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Niclosamide as an anti-obesity drug: an experimental study.Eating and weight disorders : EWD · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Michael TurchianoDepartments of Psychiatry, New York University School of Medicine, New York, NY 10016, USA.
Victoria Sweat
Arthur Fierman
Antonio Convit
New York University · US

Funding

Hormones: Molecular Mechanism of Action and FunctionsT32DK007328 · NIDDK · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI KOUSTENI, STAVROULA · 1986 to 2025
$7.8M
CONTROL OF TRANSCRIPTION TERMINATION IN E. COLIR01GM037219 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI GOTTESMAN, MAX ELLIOT · 1986 to 2017
$6.6M
NIDDK NIH HHS T32 DK007328NIDDK NIH HHS T32DK007328-31NIGMS NIH HHS R01 GM037219
6 · The paper itself

Abstract

objectivesTo determine the point prevalences of metabolic syndrome (MetS) and its components among healthy weight, overweight, and obese inner-city public high school students, to compare the prevalences of MetS when using 2 different definitions (one with the impaired fasting glucose [IFG] level and the other with a homeostasis model assessment of insulin resistance [HOMA-IR] of 3.99 or higher to define the glucose regulation component), and to compare the degree to which HOMA-IR and fasting glucose level are associated with the other MetS components.

designCross-sectional analysis.

settingTwo New York City public high schools, from April 2008 through August 2011.

participantsConvenience sample of 1185 high school youth, comprising predominantly Hispanic and African American students from low-income households, participating in The Banishing Obesity and Diabetes in Youth Project, a medical screening and education program.

main outcome measuresPrevalences of the following individual MetS components: IFG threshold, HOMA-IR, hypertension, central adiposity, hypertriglyceridemia, and low high-density lipoprotein cholesterol. Rates of MetSIFG and MetSHOMA-IR were also assessed.

resultsMetSIFG and MetSHOMA-IR point prevalences were both 0.3% in the healthy weight group; they were 2.6% and 5.9%, respectively, in the overweight group and were 22.9% and 35.1%, respectively, in the obese group (P < .05 for both). An IFG threshold of 100 mg/dL or higher was found in 1.0% of participants, whereas a HOMA-IR of 3.99 or higher was found in 19.5% of participants.

conclusionsAn elevated HOMA-IR is much more sensitive than an IFG threshold in identifying adolescents with metabolic dysregulation. Using a HOMA-IR threshold of 3.99 identifies more youth with MetS than using an IFG threshold of 100 mg/dL. In addition to increasing the sensitivity of MetS detection, HOMA-IR has a much higher association with the other MetS components than the IFG threshold and may better reflect a unified underlying pathologic process useful to identify youth at risk for disease.

Indexed as

Black or African AmericanHispanic or LatinoAdolescentBiomarkersBlood GlucoseBlood PressureCross-Sectional StudiesFemaleHomeostasisHumansInsulin ResistanceLinear ModelsMaleMetabolic SyndromeMinority HealthNew York CityBiomarkersBlood Glucose

Identifiers

PMID23007727
PMCPMC3615436
OpenAlexW2111606467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.